Dose-intense chemoimmunotherapy plus radioimmunotherapy in high-risk diffuse large B-cell lymphoma and mantle cell lymphoma: a phase II study.

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Hudson, KE; Rizzieri, D; Thomas, SM; LeBlanc, TW; Powell, Z; Diehl, L; Moore, JO; DeCastro, C; Beaven, AW

Published Date

  • February 21, 2018

Published In

PubMed ID

  • 29468651

Electronic International Standard Serial Number (EISSN)

  • 1365-2141

International Standard Serial Number (ISSN)

  • 0007-1048

Digital Object Identifier (DOI)

  • 10.1111/bjh.15138

Language

  • eng